You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hypopharyngeal Neoplasms

Showing 1 - 25 of 733
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Larynx Cancer, Hypopharyngeal Cancer Trial in Shanghai (procedure, radiation, drug)

Recruiting
  • Larynx Cancer
  • Hypopharyngeal Cancer
  • Surgery
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 9, 2023

The Voice asTool to Detect Recurrence of Laryngeal and

Not yet recruiting
  • Laryngeal Cancer
  • Hypopharyngeal Cancer
  • Voice recording, ENT (Ear, Nose and Throat) examination including transnasal fiberendoscopy, and VHI-30-questionnaire
  • Bern, Switzerland
    Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Inse
May 30, 2023

Hypopharyngeal Cancer Trial (Cisplatin/Nedaplatin, albumin paclitaxel)

Not yet recruiting
  • Hypopharyngeal Cancer
  • Cisplatin/Nedaplatin, albumin paclitaxel
  • (no location specified)
May 5, 2023

Squamous Cell Carcinoma of the Larynx, Squamous Cell Carcinoma of the Hypopharynx Trial in Rotterdam (CRGD-ZW800-1)

Not yet recruiting
  • Squamous Cell Carcinoma of the Larynx
  • Squamous Cell Carcinoma of the Hypopharynx
  • Rotterdam, Zuid-Holland, Netherlands
    Erasmus Medical Center
Feb 21, 2023

Laryngeal Cancer, Hypopharyngeal Cancer Trial in Shanghai (Toripalimab)

Recruiting
  • Laryngeal Cancer
  • Hypopharyngeal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 12, 2022

Immune Biomarker Study for Head and Neck Cancer

Recruiting
  • Head and Neck Cancer
  • +4 more
  • Sampling
  • Erlangen, Bavaria, Germany
  • +2 more
Jan 23, 2023

Hypopharyngeal Cancer, Immunotherapy, Induction Chemo Trial in Guangzhou (Camrelizumab)

Recruiting
  • Hypopharyngeal Cancer
  • +2 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Aug 14, 2021

Laryngeal Disease, Laryngeal Lesions, Hypopharyngeal Lesions Trial in Ostrava, Hradec Králové (Enhanced contact endoscopy,

Recruiting
  • Laryngeal Disease
  • +6 more
  • Enhanced contact endoscopy
  • +2 more
  • Ostrava, Moravian-Silesian Region, Czechia
  • +1 more
Jun 29, 2021

Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer Trial in

Completed
  • Carcinoma, Squamous Cell of Head and Neck
  • +5 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 24, 2022

Malignant Tumor of Oropharynx Stage III, Malignant Tumor of Larynx Stage III, Malignant Tumor of Hypopharynx Stage III Trial in

Recruiting
  • Malignant Neoplasm of Oropharynx Stage III
  • +7 more
  • Escalated Dose
  • Standard Dose
  • Kolkata, West Bengal, India
    Tata Medical Centre
Dec 2, 2021

Blood Tests and Questionnaires in Studying Adherence to

Recruiting
  • Carcinoma of Unknown Primary
  • +30 more
  • Biospecimen Collection
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Dec 12, 2022

Laryngeal Cancer, Hypopharynx Cancer, Laryngeal Tumors Trial in Shanghai (chemo TP regimen combined with Toripalimab)

Recruiting
  • Laryngeal Cancer
  • +2 more
  • chemotherapy TP regimen combined with Toripalimab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 2, 2022

Caregiver, Malignant Head and Neck Tumor, Paranasal Sinus Squamous Cell Carcinoma Trial in Winston-Salem (Communication

Completed
Has Results
  • Caregiver
  • +37 more
  • Communication Intervention
  • +5 more
  • Winston-Salem, North Carolina
    Comprehensive Cancer Center of Wake Forest University
Dec 14, 2022

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma Stage III

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • KEYTRUDA®
  • (no location specified)
Nov 17, 2023

Hypopharyngeal Cancer Trial in Beijing (Induction CT+ CRT group, Concurrent CRT group)

Recruiting
  • Hypopharyngeal Cancer
  • Induction CT+ CRT group
  • Concurrent CRT group
  • Beijing, China
    Cancer hospital, Chinese Academy of Medical Sciences
Jan 28, 2021

Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +23 more
  • Biospecimen Collection
  • +2 more
  • Los Angeles, California
  • +1 more
Jul 7, 2022

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

Recruiting
  • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +28 more
  • San Francisco, California
    University of California, San Francisco
Dec 16, 2022

Active, not recruiting
  • Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
  • +8 more
  • Cetuximab
  • +3 more
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute (UPCI)
Jan 26, 2023

Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer Trial in Shanghai (5-Fluorouracil, Cisplatin, Toripalimab)

Recruiting
  • Locoregionally Advanced Laryngo-hypopharyngeal Squamous Cell Cancer
  • 5-Fluorouracil, Cisplatin, Toripalimab
  • Shanghai, China
    Department of Oncology, Ruijin Hospital
Jun 14, 2021

Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

Not yet recruiting
  • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
  • +15 more
  • Best Practice
  • +9 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Aug 23, 2022

Head and Neck Carcinoma of Unknown Primary, Locally Advanced Head and Neck Squamous Cell Carcinoma, Locally Advanced

Recruiting
  • Head and Neck Carcinoma of Unknown Primary
  • +24 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Aug 6, 2022

Hypopharyngeal Tumor Malignant Primary Trial in Beijing (Toripalimab)

Not yet recruiting
  • Hypopharyngeal Neoplasm Malignant Primary
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Nov 5, 2020

Oral Cancer, Hypopharyngeal Cancer Trial in Taichung City (Specific acupuncture group, Metoclopramide 10mg, Non-specific

Completed
  • Oral Cancer
  • Hypopharyngeal Cancer
  • Specific acupuncture group
  • +2 more
  • Taichung City, Taichung, Taiwan
    surgical and burn intensive care departments and the plastic sur
Mar 23, 2021

Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous

Suspended
  • Advanced Head and Neck Squamous Cell Carcinoma
  • +17 more
  • Gilbert, Arizona
  • +19 more
Dec 31, 2022